Clinical Decision Support Systems (CDSS) Market Report by Component (Hardware, Software, Services), Product (Integrated CDSS, Standalone CDSS), Type (Therapeutic, Diagnostic), Delivery Mode (On Premise, Cloud Based), Model (Knowledge Based, Non-Knowledge

Clinical Decision Support Systems (CDSS) Market Report by Component (Hardware, Software, Services), Product (Integrated CDSS, Standalone CDSS), Type (Therapeutic, Diagnostic), Delivery Mode (On Premise, Cloud Based), Model (Knowledge Based, Non-Knowledge Based), Application (Drug Allergy Alerts, Clinical Guidelines, Drug-Drug Interactions, Clinical Reminders, and Others), and Region 2024-2032


The global clinical decision support systems (CDSS) market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a CAGR of 6.72% during 2024-2032. The increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors represent some of the key factors driving the market.

The clinical decision support system (CDSS) refers to a specialized information computer-based application designed to analyze data within electronic health record (EHR) record systems. It provides reminders to clinicians, physicians, and staff to suggest better clinical treatments for effective patient care. It employs various hardware and software-based solutions, such as cloud storage, which helps manage and store an excessive amount of accessible clinical and administrative data. CDSS assists in enhancing healthcare delivery by making complex medical decisions with targeted clinical and health-related information, streamlines the workflow, inhibits the risk of medication errors, reduces misdiagnoses, and helps in executing diverse administrative operations. Apart from this, it manages medical practices, provides reliable information and observations, and optimizes overall operational efficiency. As a result, CDSS is used by hospitals and clinics to provide drug allergy alerts and ensure better clinical outcomes by providing exceptional care to patients.

The increasing need for various advanced systems with specialized algorithms, interactive interfaces, and service-oriented architectures, including CDSS solutions to treat several chronic disorders, is primarily driving the market toward growth. In line with this, the escalating instances of medication errors due to human intervention have intensified the widespread adoption of CDSS in the healthcare sector to make better clinical decisions, which is acting as another growth-inducing factor. Additionally, favorable initiatives undertaken by governments of various countries to promote the uptake of health information and communication technology (HICT) in hospital settings are favoring the market growth. Such products help provide high-quality care to patients at lower expenditure by furnishing health workers with reliable data. Moreover, the large-scale integration of artificial intelligence (AI), machine learning (ML), computerized provider order entry (CPOE), and statistical pattern recognition solutions to analyze data measurements for extracting information is propelling the market growth. These technologies can be further administered through multiple consumer electronic devices, such as desktops, tablets, biometric monitoring systems, and wearable devices, which is impelling the market growth. Apart from this, significant enhancements in the healthcare infrastructure, growing consumer awareness regarding its availability and beneficial properties, and ongoing mergers and acquisitions (M&A) amongst key players to engineer advanced CDSS solutions are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the clinical decision support systems (CDSS) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on component, product, type, delivery mode, model, and application.

Component Insights:

Hardware
Software
Services

The report has provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the component. This includes hardware, software and services. According to the report, services represented the largest segment.

Product Insights:

Integrated CDSS
Standalone CDSS

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the product has also been provided in the report. This includes integrated and standalone CDSS. According to the report, integrated CDSS accounted for the largest market share.

Type Insights:

Therapeutic
Diagnostic

The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the type. This includes therapeutic and diagnostic. According to the report, therapeutic represented the largest segment.

Delivery Mode Insights:

On Premise
Cloud Based

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the delivery mode has also been provided in the report. This includes on premise and cloud based. According to the report, on-premise accounted for the largest market share.

Model Insights:

Knowledge Based
Non-Knowledge Based

The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the model. This includes knowledge and non-knowledge based. According to the report, knowledge based represented the largest segment.

Application Insights:

Drug Allergy Alerts
Clinical Guidelines
Drug-Drug Interactions
Clinical Reminders
Others

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the application has also been provided in the report. This includes drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders and others. According to the report, drug allergy alert accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for clinical decision support systems. Some of the factors driving the North America clinical decision support system market included the increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors.

Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global clinical decision support system market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Athenahealth Inc., Change Healthcare (United Health Group Incorporated), Epic Systems Corporation, General Electric Company, International Business Machines Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Oracle Corporation, Siemens Healthineers AG (Siemens AG), Wolters Kluwer N.V., Zynx Health Incorporated (Hearst Business Media Corporation), etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global clinical decision support systems (CDSS) market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global clinical decision support systems (CDSS) market?
What are the key regional markets?
Which countries represent the most attractive clinical decision support systems (CDSS) markets?
What is the breakup of the market based on the component?
What is the breakup of the market based on the product?
What is the breakup of the market based on the type?
What is the breakup of the market based on the delivery mode?
What is the breakup of the market based on the model?
What is the breakup of the market based on the application?
What is the competitive structure of the global clinical decision support systems (CDSS) market?
Who are the key players/companies in the global clinical decision support systems (CDSS) market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Clinical Decision Support Systems (CDSS) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Hardware
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Software
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Integrated CDSS
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Standalone CDSS
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Type
8.1 Therapeutic
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Delivery Mode
9.1 On Premise
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cloud Based
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Model
10.1 Knowledge Based
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Non-Knowledge Based
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Application
11.1 Drug Allergy Alerts
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Clinical Guidelines
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Drug-Drug Interactions
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Clinical Reminders
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Others
11.5.1 Market Trends
11.5.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 Drivers, Restraints, and Opportunities
13.1 Overview
13.2 Drivers
13.3 Restraints
13.4 Opportunities
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Athenahealth Inc.
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.2 Change Healthcare (UnitedHealth Group Incorporated)
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 Financials
17.3.3 Epic Systems Corporation
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 SWOT Analysis
17.3.4 General Electric Company
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 Financials
17.3.4.4 SWOT Analysis
17.3.5 International Business Machines Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Koninklijke Philips N.V.
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.6.4 SWOT Analysis
17.3.7 NextGen Healthcare Inc.
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 Oracle Corporation
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Siemens Healthineers AG (Siemens AG)
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 Wolters Kluwer N.V.
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 Financials
17.3.10.4 SWOT Analysis
17.3.11 Zynx Health Incorporated (Hearst Business Media Corporation)
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings